Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma.
In conclusion, the present study demonstrated that RHPN2 may promote PDAC making it a potential candidate for targeted therapy.
PMID: 33365087 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Genetics | Pancreas | Pancreatic Cancer | Study